FDA Inspection
Dr. Bruce G. Rankin, DODr. Bruce G. Rankin, DO – FDA Inspection, Jan 12, 2010
Record Details
This FDA Inspection record concerns Dr. Bruce G. Rankin, DO, with an inspection on January 12, 2010, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Dr. Bruce G. Rankin, DO
- Inspection Date
- January 12, 2010
- Product Type
- Drugs
View Company Profile
ID · 12a208d9-8b16-4284-9c95-abc930c5b10b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 646078
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 312.50General responsibilities of sponsors
- 21 CFR 312.66Unanticipated problems
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Dr. Bruce G. Rankin, DO
5| Date | Classification | Office | Project area |
|---|---|---|---|
| September 22, 2023 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| November 24, 2020 | NAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
| May 8, 2015 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 25, 2014 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| January 26, 2010 | NAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
Other documents for Dr. Bruce G. Rankin, DO
- FDA Inspection 1218367 - 2023-09-22
- FDA Inspection 1133732 - 2020-11-24
- FDA Inspection 927571 - 2015-05-08
- FDA Inspection 867756 - 2014-02-25
- FDA Inspection 642563 - 2010-01-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.